Illumina (ILMN)

Add to Watchlists
Create an Alert
135.45 -0.77  -0.57% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Illumina Research and Development Expense (Quarterly):

76.73M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Illumina Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Illumina Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 76.73M
Sept. 30, 2013 70.96M
June 30, 2013 67.61M
March 31, 2013 61.45M
Dec. 31, 2012 56.91M
Sept. 30, 2012 54.06M
June 30, 2012 71.22M
March 31, 2012 48.84M
Dec. 31, 2011 45.51M
Sept. 30, 2011 50.40M
June 30, 2011 50.80M
March 31, 2011 50.20M
Dec. 31, 2010 45.80M
Sept. 30, 2010 44.80M
June 30, 2010 43.67M
March 31, 2010 43.68M
Dec. 31, 2009 40.37M
Sept. 30, 2009 34.41M
June 30, 2009 33.12M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

ILMN Research and Development Expense (Quarterly) Benchmarks

Companies
Actelion 132.21M
Affymetrix 11.98M
Amgen 1.249B

ILMN Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 33.12M Jun 2009
Maximum 76.73M Dec 2013
Average 52.13M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.